(ALBLD) Bilendi - Ratings and Ratios
Market Research, Customer Engagement, AI, Loyalty, CRM
Description: ALBLD Bilendi
Bilendi SA is a multifaceted market research and customer engagement entity operating across Europe and beyond, providing an array of services that facilitate businesses understanding of their clientele and foster loyalty. The companys suite of services encompasses translation, scripting, sampling, quality assurance, coding, and data processing, thereby catering to the nuanced needs of market research. Notably, Bilendi has developed cutting-edge tools such as Bilendi Discuss, an AI-driven qualitative research platform, augmented by its proprietary Artificial Research Intelligence AI assistant, which integrates in-house algorithms with the capabilities of ChatGPT. This technological prowess is further exemplified by its Niche recruitment service, leveraging social media to access and interview niche targets globally, and the application of AI in quantitative projects, underscoring its commitment to innovation.
The companys diversified portfolio extends beyond market research to include loyalty and CRM consulting, technologies, data insights, digital marketing, and rewards and incentives services, positioning it as a holistic solutions provider for businesses seeking to enhance customer engagement and retention. With a history dating back to 1999, when it was incorporated as Maximiles SA before rebranding to Bilendi SA, the company has established a strong presence in the industry, headquartered in Paris, France. Its operational footprint spans multiple countries, including France, the UK, Germany, Switzerland, Spain, Italy, Morocco, Denmark, Sweden, Finland, Belgium, the Netherlands, and Mauritius, making it a significant player in the global market research and customer engagement landscape.
Analyzing the technical data, Bilendis stock (ALBLD) is currently trading at €23.40, having reached its 52-week high. The stocks short-term and long-term moving averages (SMA20 at €19.98, SMA50 at €19.70, and SMA200 at €17.40) indicate a bullish trend, suggesting sustained investor interest and potential for further growth. The Average True Range (ATR) of 0.84, representing a 3.58% volatility, indicates moderate daily price fluctuations. Considering the fundamental data, Bilendis market capitalization stands at €87.61M, with a Price-to-Earnings (P/E) ratio of 20.10 and a Return on Equity (RoE) of 20.04%, signaling a relatively healthy financial position and investor confidence.
Forecasting Bilendis stock performance, the confluence of its technical and fundamental data suggests a positive outlook. The stocks current price is above its short-term and long-term moving averages, indicating a strong upward trend. The absence of a forward P/E ratio complicates earnings projections, but the current P/E and RoE suggest the company is generating value for its shareholders. Given these indicators, its plausible that Bilendi will continue to attract investors, potentially driving the stock price higher. However, the moderate volatility, as indicated by the ATR, necessitates cautious monitoring of market dynamics. A potential target price could be derived by analyzing the historical volatility and growth trends, suggesting a possible increase in stock price, potentially testing new highs in the coming months.
ALBLD Stock Overview
Market Cap in USD | 112m |
Sub-Industry | Advertising |
IPO / Inception | 2005-07-05 |
ALBLD Stock Ratings
Growth Rating | 50.2% |
Fundamental | 86.9% |
Dividend Rating | - |
Return 12m vs S&P 500 | -2.76% |
Analyst Rating | - |
ALBLD Dividends
Currently no dividends paidALBLD Growth Ratios
Growth Correlation 3m | -58.2% |
Growth Correlation 12m | 85.7% |
Growth Correlation 5y | 29.7% |
CAGR 5y | 10.51% |
CAGR/Max DD 5y | 0.16 |
Sharpe Ratio 12m | -0.10 |
Alpha | 9.72 |
Beta | 0.118 |
Volatility | 41.53% |
Current Volume | 3.5k |
Average Volume 20d | 1.4k |
Stop Loss | 18.8 (-3.3%) |
Signal | -1.27 |
Piotroski VR‑10 (Strict, 0-10) 7.5
Net Income (31.1m TTM) > 0 and > 6% of Revenue (6% = 7.28m TTM) |
FCFTA 0.25 (>2.0%) and ΔFCFTA 22.09pp (YES ≥ +1.0pp, WARN ≥ +0.5pp) |
NWC/Revenue 15.30% (prev 13.58%; Δ 1.72pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp) |
CFO/TA 0.29 (>3.0%) and CFO 22.7m <= Net Income 31.1m (YES >=105%, WARN >=100%) |
Net Debt (-4.28m) to EBITDA (20.5m) ratio: -0.21 <= 3.0 (WARN <= 3.5) |
Current Ratio 1.93 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active) |
Outstanding Shares last Quarter (4.76m) change vs 12m ago -0.65% (target <= -2.0% for YES) |
Gross Margin 39.35% (prev 17.38%; Δ 21.97pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0) |
Asset Turnover 153.4% (prev 115.5%; Δ 37.91pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0) |
Interest Coverage Ratio 27.81 (EBITDA TTM 20.5m / Interest Expense TTM 416.6k) >= 6 (WARN >= 3) |
Altman Z'' 3.46
(A) 0.23 = (Total Current Assets 38.4m - Total Current Liabilities 19.9m) / Total Assets 79.4m |
(B) 0.06 = Retained Earnings (Balance) 4.46m / Total Assets 79.4m |
(C) 0.15 = EBIT TTM 11.6m / Avg Total Assets 79.1m |
(D) 0.72 = Book Value of Equity 28.0m / Total Liabilities 38.7m |
Total Rating: 3.46 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D) |
ValueRay F-Score (Strict, 0-100) 86.90
1. Piotroski 7.50pt = 2.50 |
2. FCF Yield 18.36% = 5.0 |
3. FCF Margin 16.17% = 4.04 |
4. Debt/Equity 0.28 = 2.46 |
5. Debt/Ebitda 0.55 = 2.27 |
6. ROIC - WACC 9.82% = 12.28 |
7. RoE 85.70% = 2.50 |
8. Rev. Trend 58.38% = 2.92 |
9. Rev. CAGR 8.21% = 1.03 |
10. EPS Trend 5.72% = 0.14 |
11. EPS CAGR 17.59% = 1.76 |
What is the price of ALBLD shares?
Over the past week, the price has changed by -8.25%, over one month by -11.59%, over three months by -17.23% and over the past year by +13.74%.
Is Bilendi a good stock to buy?
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of ALBLD is around 17.26 EUR . This means that ALBLD is currently overvalued and has a potential downside of -11.26%.
Is ALBLD a buy, sell or hold?
What are the forecasts/targets for the ALBLD price?
Issuer | Target | Up/Down from current |
---|---|---|
Wallstreet Target Price | 27 | 39% |
Analysts Target Price | - | - |
ValueRay Target Price | 18.8 | -3.3% |
ALBLD Fundamental Data Overview
Market Cap EUR = 95.9m (95.9m EUR * 1.0 EUR.EUR)
CCE Cash And Equivalents = 337.2k EUR (last quarter)
P/E Trailing = 21.8085
P/S = 1.4902
P/B = 2.3179
Beta = 0.761
Revenue TTM = 121.3m EUR
EBIT TTM = 11.6m EUR
EBITDA TTM = 20.5m EUR
Long Term Debt = 8.78m EUR (from longTermDebt, last quarter)
Short Term Debt = 2.49m EUR (from shortTermDebt, last quarter)
Debt = 11.3m EUR (Calculated: Short Term 2.49m + Long Term 8.78m)
Net Debt = -4.28m EUR (from netDebt column, last quarter)
Enterprise Value = 106.9m EUR (95.9m + Debt 11.3m - CCE 337.2k)
Interest Coverage Ratio = 27.81 (Ebit TTM 11.6m / Interest Expense TTM 416.6k)
FCF Yield = 18.36% (FCF TTM 19.6m / Enterprise Value 106.9m)
FCF Margin = 16.17% (FCF TTM 19.6m / Revenue TTM 121.3m)
Net Margin = 25.66% (Net Income TTM 31.1m / Revenue TTM 121.3m)
Gross Margin = 39.35% ((Revenue TTM 121.3m - Cost of Revenue TTM 73.6m) / Revenue TTM)
Tobins Q-Ratio = 3.82 (Enterprise Value 106.9m / Book Value Of Equity 28.0m)
Interest Expense / Debt = 2.29% (Interest Expense 257.7k / Debt 11.3m)
Taxrate = 33.23% (from yearly Income Tax Expense: 2.23m / 6.70m)
NOPAT = 7.74m (EBIT 11.6m * (1 - 33.23%))
Current Ratio = 1.93 (Total Current Assets 38.4m / Total Current Liabilities 19.9m)
Debt / Equity = 0.28 (Debt 11.3m / last Quarter total Stockholder Equity 40.4m)
Debt / EBITDA = 0.55 (Net Debt -4.28m / EBITDA 20.5m)
Debt / FCF = 0.57 (Debt 11.3m / FCF TTM 19.6m)
Total Stockholder Equity = 36.3m (last 4 quarters mean)
RoA = 39.24% (Net Income 31.1m, Total Assets 79.4m )
RoE = 85.70% (Net Income TTM 31.1m / Total Stockholder Equity 36.3m)
RoCE = 25.68% (Ebit 11.6m / (Equity 36.3m + L.T.Debt 8.78m))
RoIC = 15.76% (NOPAT 7.74m / Invested Capital 49.1m)
WACC = 5.93% (E(95.9m)/V(107.2m) * Re(6.45%)) + (D(11.3m)/V(107.2m) * Rd(2.29%) * (1-Tc(0.33)))
Shares Correlation 5-Years: 70.0 | Cagr: 3.60%
Discount Rate = 6.45% (= CAPM, Blume Beta Adj.) -> floored to rf + ERP 8.05%
[DCF Debug] Terminal Value 70.46% ; FCFE base≈12.6m ; Y1≈8.27m ; Y5≈3.78m
Fair Price DCF = 16.13 (DCF Value 74.4m / Shares Outstanding 4.61m; 5y FCF grow -40.0% → 3.0% )
Revenue Correlation: 58.38 | Revenue CAGR: 8.21%
Rev Growth-of-Growth: -59.05
EPS Correlation: 5.72 | EPS CAGR: 17.59%
EPS Growth-of-Growth: 255.1